Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine. (Q30279055)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Samantha G Sherwood

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Kelly C Drews

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Mark Kester

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

7 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

208-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

Hallmarks of Cancer: The Next Generation

18 February 2020

cites work

1 reference

Tumour heterogeneity and cancer cell plasticity

21 January 2018

1 reference

Microenvironmental regulation of tumor progression and metastasis

21 January 2018

1 reference

The tumor microenvironment: a target for combination therapy of breast cancer

21 January 2018

1 reference

Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma

21 January 2018

1 reference

Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity

21 January 2018

1 reference

Therapeutic targeting of tumor-stroma interactions.

21 January 2018

1 reference

Targeting the tumor stroma as a novel therapeutic approach for prostate cancer.

21 January 2018

1 reference

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

21 January 2018

1 reference

pH-sensitive nano-systems for drug delivery in cancer therapy

21 January 2018

1 reference

Recent progress in tumor pH targeting nanotechnology

21 January 2018

1 reference

pH-responsive nanoparticles for cancer drug delivery

21 January 2018

1 reference

Stimuli-sensitive nanopreparations for combination cancer therapy

21 January 2018

1 reference

Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy

21 January 2018

1 reference

The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy

21 January 2018

1 reference

TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event

21 January 2018

1 reference

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

21 January 2018

1 reference

Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer

21 January 2018

1 reference

Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug.

21 January 2018

1 reference

Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model

21 January 2018

1 reference

Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers

21 January 2018

1 reference

In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading

21 January 2018

1 reference

A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways.

21 January 2018

1 reference

Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan

21 January 2018

1 reference

Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts.

21 January 2018

1 reference

Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model.

21 January 2018

1 reference

Drug combination studies and their synergy quantification using the Chou-Talalay method

21 January 2018

1 reference

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells

21 January 2018

1 reference

Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics

21 January 2018

1 reference

A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions

21 January 2018

1 reference

Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia

21 January 2018

1 reference

Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery

21 January 2018

1 reference

Controlled release of a sparingly water-soluble anticancer drug through pH-responsive functionalized gold-nanoparticle-decorated liposomes.

21 January 2018

1 reference

Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy

21 January 2018

1 reference

Safe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicity

21 January 2018

1 reference

Improvement of the antiproliferative effect of rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes.

21 January 2018

1 reference

pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy

21 January 2018

1 reference

pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells

21 January 2018

1 reference

Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes

21 January 2018

1 reference

pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.

21 January 2018

1 reference

Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: therapeutic effect in rabbit Vx2 tumours

21 January 2018

1 reference

Hyperthermia-induced drug delivery from thermosensitive liposomes encapsulated in an injectable hydrogel for local chemotherapy

21 January 2018

1 reference

In vitro localized release of thermosensitive liposomes with ultrasound-induced hyperthermia

21 January 2018

1 reference

Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy

21 January 2018

1 reference

Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound

21 January 2018

1 reference

Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).

21 January 2018

1 reference

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

21 January 2018

1 reference

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

21 January 2018

1 reference

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

21 January 2018

1 reference

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

21 January 2018

1 reference

Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells.

21 January 2018

1 reference

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.

21 January 2018

1 reference

Topotecan and doxorubicin combination to treat recurrent ovarian cancer: the influence of drug exposure time and delivery systems to achieve optimum therapeutic activity

21 January 2018

1 reference

Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft

21 January 2018

1 reference

Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors

21 January 2018

1 reference

Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development

21 January 2018

1 reference

Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma

21 January 2018

1 reference

Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.

21 January 2018

1 reference

Nanomedicine(s) under the microscope

21 January 2018

1 reference

Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy

21 January 2018

1 reference

Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model

21 January 2018

1 reference

Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer

21 January 2018

1 reference

The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.

21 January 2018

1 reference

Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.

21 January 2018

1 reference

Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models

21 January 2018

1 reference

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.

21 January 2018

1 reference

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

21 January 2018

1 reference

In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags

21 January 2018

1 reference

iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance

21 January 2018

1 reference

Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression

21 January 2018

1 reference

Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer

21 January 2018

1 reference

In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles

21 January 2018

1 reference

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

21 January 2018

1 reference

Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo.

21 January 2018

1 reference

Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer

21 January 2018

1 reference

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

Radionanomedicine: widened perspectives of molecular theragnosis

21 January 2018

1 reference

Image-guided nanosystems for targeted delivery in cancer therapy

21 January 2018

1 reference

Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases

21 January 2018

1 reference

In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.

21 January 2018

1 reference

Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity

21 January 2018

1 reference

Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells

21 January 2018

1 reference

12 December 2020

Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer

1 reference

12 December 2020

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy.

1 reference

12 December 2020

Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratios

1 reference

12 December 2020

Gastrointestinal toxicity or irinotecan

1 reference

12 December 2020

Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy

1 reference

12 December 2020

Doxorubicin-induced cardiomyopathy

1 reference

12 December 2020

Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase

1 reference

12 December 2020

Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia

1 reference

12 December 2020

Therapeutic strategies for targeting the ovarian tumor stroma

1 reference

12 December 2020

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

1 reference

12 December 2020

Tumoritropic and lymphotropic principles of macromolecular drugs

1 reference

12 December 2020

Identifiers

DOI

10.1002/WNAN.1358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26153136%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference